Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

See all formats and pricing
More options …
Volume 46, Issue 7


Microbial safety of cell based medicinal products – what can we learn from cellular blood components?

Thomas Montag / Sven-Boris Nicol / Utta Schurig / Margarete Heiden / Helga Huber / Ralf Sanzenbacher / Egbert Flory / Michael Schwanig / Christian K. Schneider


Today, sterility of established parenteral drugs including biologicals, such as plasma derived products, is practically guaranteed. Bacterially contaminated products are extremely rare exceptions owing to the efficiency of the manufacturing processes in the pharmaceutical industry. In contrast, the manufacturing processes of cell based medicinal products or tissue preparations show much less defined conditions. The sterility of source materials cannot be guaranteed in many cases. As a rule, these source materials cannot be sterilised, as it holds true for the final products. Furthermore, the established methods for sterility testing are not applicable for cell preparations. Sterility of a restricted sample does not guarantee sterility of the whole preparation. Thus, small amounts of residual bacteria in the product can be overlooked and can grow up to enormous numbers during storage and shipping of cell based medicinal products. Considering these problems, there are some parallels in the warranty of microbial safety of cellular blood components. Therefore, the experiences collected in transfusion medicine in the past decade can be successfully used in the production of cell based medicinal products. Comparable to the situation regarding cellular blood components, there is a need for new principles in rapid bacteria detection.

Clin Chem Lab Med 2008;46:963–5.

About the article

Corresponding author: Thomas Montag-Lessing, MD, Paul-Ehrlich-Institute, Paul-Ehrlich-Straße 51–59, 63225 Langen, Germany

Published in Print: 2008-07-01

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 46, Issue 7, Pages 963–965, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2008.175.

Export Citation

©2008 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

M. Störmer, E. M. Wood, U. Schurig, O. Karo, I. Spreitzer, C. P. McDonald, and T. Montag
Vox Sanguinis, 2014, Volume 106, Number 4, Page 285
M. M. Mueller, M. K. Hourfar, E. Huber, W. Sireis, W. Weichert, E. Seifried, T. Tonn, and M. Schmidt
Transfusion Medicine, 2012, Volume 22, Number 3, Page 211
Cherie Mastronardi, Lin Yang, Mike Halpenny, Baldwin Toye, and Sandra Ramírez-Arcos
Transfusion, 2012, Volume 52, Number 8, Page 1778
Michael Schmidt, Walid Sireis, and Erhard Seifried
Transfusion Medicine and Hemotherapy, 2011, Volume 38, Number 4, Page 259
T. Montag-Lessing, M. Störmer, U. Schurig, J. Brachert, M. Bubenzer, U. Sicker, R. Beshir, I. Spreitzer, B. Löschner, C. Bache, B. Becker, and C.K. Schneider
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2010, Volume 53, Number 1, Page 45

Comments (0)

Please log in or register to comment.
Log in